E. David Crawford, M.D. - Chairman
Chairman of PCEC since 1989. Dr. Crawford is professor of surgery, professor of radiation oncology, and head of the Section of Urologic Oncology at the University of Colorado Health Sciences Center (UCHSC) in Denver.
Leonard G. Gomella, MD, FACS
Dr. Leonard Gomella is the Bernard W. Godwin, Jr. Professor of Prostate Cancer and Chairman of the Department of Urology at Jefferson Medical College, and the Associate Director for Clinical Affairs at the Kimmel Cancer Center. Additionally, Dr. Gomella is the Urology Chair for RTOG, serving as lead Urology investigator on multiple national trials. He has served as President of the Mid-Atlantic section of the AUA and is currently the Society of Urologic Oncology President Elect.
Michael D. Lutz, M.D.
Dr. Michael Lutz is a partner in the Michigan Institute of Urology, P.C.. He is experienced in all areas of adult Urology and has special interest in Urologic Oncology, Male Fertility and Urologic Stone Disease.
Colonel David G. McLeod, M.D., J.D.
Colonel David G. McLeod, M.D., is Chief of Urologic Oncology at Walter Reed Army Medical Center, Washington, DC and Professor of Surgery at the Uniformed Services University of the Health Sciences, Bethesda, MD. Doctor McLeod is also Director of the Urology Residency Program at Walter Reed Army Medical Center and Clinical Professor in the Department of Surgery (Urology) at Georgetown University Medical Center.
Mark A. Moyad, M.D., MPH
Dr. Moyad received his master’s degree in public health from the University of South Florida where he was one of the lead investigators of the L-tryptophan dietary supplement study that helped to remove this dangerous supplement from the market.
Alan W. Partin, M.D., Ph.D.
Alan W.Partin M.D., Ph.D., Professor of Urology the Johns Hopkins Medical Institution, has both basic science and clinical interest in prognosis prediction for men with prostate cancer.
Daniel P. Petrylak, M.D.
Daniel P. Petrylak, MD, recently named Leader of Prostate Medical Oncology at Yale Cancer Center in New Haven, CT. Dr. Petrylak, an internationally known medical oncologist, to lead the genitourinary cancers medical oncology team at Smilow Cancer Hospital and as director of the prostate cancer research group and co-director of the Signal Transduction Research Program. Dr. Petrylak joins Yale from NewYork-Presbyterian Hospital/Columbia University Medical Center.
Wendy L. Poage, MHA
Wendy Poage earned her Bachelor of Science degree at the Colorado State University in 1993 and her Masters of Health Care Administration at Webster University in 1997. Wendy has been the President of the Prostate Conditions Education Council since 1998 and the Administrator of Urologic Oncology at the University of Colorado Health Sciences Center for over ten years.
Neal Shore, M.D., F.A.C.S.
Neal D. Shore, MD, FACS, is the Medical Director of the Carolina Urologic Research Center. Dr. Shore has conducted more than 100 clinical trials, focusing mainly on prostate and bladder disease.
Nelson N. Stone, M.D.
Nelson Neal Stone, M.D. is an Attending Physician in the Departments of Urology and Radiation Oncology at Mount Sinai Medical Center in New York City. He is also a Clinical Professor of Urology and Radiation Oncology at Mount Sinai School of Medicine and at the Derald H. Ruttenberg Cancer Center at Mount Sinai.
Frank Staggers, M.D.
In Loving Memory
Dr. Staggers was a founding member of PCEC and his leadership will be dearly missed, but his work and legacy in educating physicians and patients will continue on with PCEC.